BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

DelSite Biotechnologies, Inc. 

1505 Walnut Hill Lane

Irving  Texas  75038  U.S.A.
Phone: 972-717-5009 Or 800-358-5213
Fax: 972-871-1132


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
DelSite Biotechnologies, Inc. Announces Intention to License Manapol(R) Manufacturing Rights, Fields of Use and Territories 2/18/2009 11:23:17 AM
DelSite Biotechnologies, Inc.. Discontinues Manufacturing Operations; Receives FDA Approval to Initiate Phase I Clinical Study for GelVac(TM) Nasal Powder Bird Flu Vaccine 1/26/2009 12:04:45 PM
DelSite Biotechnologies, Inc. Chairman George DeMott Resigns 12/11/2008 11:40:55 AM
DelSite Biotechnologies, Inc. Presents Nasal Powder and Synthetic Typhoid Vaccine Technologies at the 2nd Vaccines Asia Conference 11/13/2008 11:06:48 AM
DelSite Biotechnologies, Inc. Reports Third Quarter 2008 Results 11/13/2008 9:44:13 AM
DelSite Biotechnologies, Inc. Patent for GelSite(R) Polymer Technology Issued 11/12/2008 9:11:31 AM
DelSite Biotechnologies, Inc. Announces Third Quarter 2008 Earnings Conference Call 11/11/2008 11:29:38 AM
DelSite Biotechnologies, Inc. Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine 8/20/2008 11:26:30 AM
DelSite Biotechnologies, Inc. Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute 8/18/2008 11:20:51 AM
DelSite Biotechnologies, Inc. Reports Second Quarter 2008 Results 8/14/2008 9:25:24 AM
1234567